Should cell culture platforms move towards EV therapy requirements?

Frontiers in Immunology

Volumn 6, Issue JAN, 2015, Pages

  Aiastui, Ana ^a  

^a BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

Author keywords

Cell culture platform; Cell therapy; EV quality service; Exosomes; Extracellular vesicle; GMP conditions

Indexed keywords

ALLOTRANSPLANTATION; CELL CULTURE; CELL THERAPY; CULTURE TECHNIQUE; EXTRACELLULAR VESICLE; GOOD MANUFACTURING PRACTICE; HEALTH CARE INDUSTRY; HEALTH CENTER; HOSPITAL; HUMAN; MEDICAL RESEARCH; NOTE; PARTICIPATORY RESEARCH; QUALITY CONTROL; SECRETORY VESICLE; TRANSLATIONAL RESEARCH;

EID: 84926654065     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00008     Document Type: Note

References (5)

1. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9(6):654-9. doi:10.1038/ncb1596
2. Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekström K, Wang X, et al. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol (2014) 11:688-701. doi:10.1038/nrurol.2014.301
3. Kranendonk ME, de Kleijn DP, Kalkhoven E, Kanhai DA, Uiterwaal CS, van der Graaf Y, et al. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease. Cardiovasc Diabetol (2014) 13:37. doi:10.1186/1475-2840-13-37
4. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia (2014) 28(4):970-3. doi:10.1038/leu.2014.41
5. Le Pecq JB. Dexosomes as a therapeutic cancer vaccine: from bench to bedside. Blood Cells Mol Dis (2005) 35(2):129-35. doi:10.1016/j.bcmd.2005.06.003